These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 6371845

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of progestins on submaxillary gland epidermal growth factor: demonstration of androgenic, synandrogenic and antiandrogenic actions.
    Bullock LP, Barthe PL, Mowszowicz I, Orth DN, Bardin CW.
    Endocrinology; 1975 Jul; 97(1):189-95. PubMed ID: 1140168
    [Abstract] [Full Text] [Related]

  • 3. 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency.
    Lemus AE, Enríquez J, García GA, Grillasca I, Pérez-Palacios G.
    J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):121-9. PubMed ID: 9182866
    [Abstract] [Full Text] [Related]

  • 4. Androgenic, synandrogenic, and antiandrogenic actions of progestins.
    Bullock LP, Bardin CW.
    Ann N Y Acad Sci; 1977 Mar 11; 286():321-30. PubMed ID: 281183
    [Abstract] [Full Text] [Related]

  • 5. Steroid receptors and hormone action: physiological and synthetic androgens and progestins can mediate inappropriate biological effects.
    Jänne OA, Bardin CW.
    Pharmacol Rev; 1984 Jun 11; 36(2 Suppl):35S-42S. PubMed ID: 6382356
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vivo metabolism and binding of 6 alpha-methylprogesterone; a progestin with anti-androgenic and synandrogenic activities.
    Brown TR, Bullock LP, Bardin CW.
    Adv Exp Med Biol; 1979 Jun 11; 117():269-80. PubMed ID: 474281
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of a nonsteroidal antiandrogen, flutamide, on androgen receptor dynamics and ornithine decarboxylase gene expression in mouse kidney.
    Kontula KK, Seppänen PJ, van Duyne P, Bardin CW, Jänne OA.
    Endocrinology; 1985 Jan 11; 116(1):226-33. PubMed ID: 3964747
    [Abstract] [Full Text] [Related]

  • 15. A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).
    Africander DJ, Storbeck KH, Hapgood JP.
    J Steroid Biochem Mol Biol; 2014 Sep 11; 143():404-15. PubMed ID: 24861265
    [Abstract] [Full Text] [Related]

  • 16. Synandrogenic and antiandrogenic effect of progestins: comparison with nonprogestational antiandrogens.
    Mowszowicz I, Bieber DE, Chung KW, Bullock LP, Bardin CW.
    Endocrinology; 1974 Dec 11; 95(6):1589-99. PubMed ID: 4373227
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterisation of gene expression patterns in 22RV1 cells for determination of environmental androgenic/antiandrogenic compounds.
    Hartel A, Didier A, Pfaffl MW, Meyer HH.
    J Steroid Biochem Mol Biol; 2003 Feb 11; 84(2-3):231-8. PubMed ID: 12711008
    [Abstract] [Full Text] [Related]

  • 19. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
    Phillips A, Hahn DW, McGuire JL.
    Am J Obstet Gynecol; 1992 Oct 11; 167(4 Pt 2):1191-6. PubMed ID: 1415445
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.